首页 > 市场调查报告书 > 医疗设备

医学影像诊断分子呈像/呈影剂

市场调查报告书

商品编码

1547495

全球造影注射器市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Contrast Injector Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球造影剂注射器市场需求预计将从 2023 年的 101526 万美元达到 2032 年近 215814 万美元的市场规模，2024-2032 年研究期间复合年增长率为 8.74%。

造影剂注射器是一种用于在 MRI 扫描期间静脉注射显影剂的机器，因为它可以提高体内静脉、动脉和组织的可见度。该设备有助于在整个成像过程中保持平滑且受控的对比度流动。它用于微创外科手术，因为它提供手术部位的高品质影像，从而帮助外科医生在适当的位置进行手术。电脑化版本被辨识为自动注射器。它能够控制注射的造影剂的量以及利用率。对于自动注射器，可以根据医学影像扫描仪的速度来调整造影剂的剂量。

市场动态

微创手术数量的增加、慢性、心臟、骨科和神经系统疾病发病率的增加以及诊断中心数量的增加是造影剂注射器市场成长的一些关键驱动因素。促进市场成长的其他因素包括政府机构的批准、政府组织的拨款以及与造影剂相关的投资的增加。此外，造影剂注射器领域的技术进步将使医学影像变得更好并推动市场成长。然而，与造影剂注射器和配件相关的高成本以及将造影剂放入註射器内的风险预计将在一定程度上阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球造影注射器市场的各个细分市场进行了包容性评估。造影剂注射器产业的成长和趋势为本研究提供了整体方法。

市场区隔

造影剂注射器市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

喷射器系统
耗材
配件

按申请

放射科
介入性心臟病学
介入放射学

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲对比注射器市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。造影剂注射器市场的主要参与者包括拜耳医疗保健、GE医疗保健、Bracco Imaging SPA、AngioDynamics、Medtron AG、Ulrich GmbH & Co. KG、Guerbet Group、Vivid Imaging、Sino Medical Device Technology Co. Ltd.、Apollo RT Co. Ltd.、Apollo RT Co. Ltd.。、以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：造影剂注射器公司的竞争格局

造影剂注射器市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Bayer HealthCare

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

Bracco Imaging SPA

公司概况
公司收入
产品
最新动态

AngioDynamics

公司概况
公司收入
产品
最新动态

Medtron AG

公司概况
公司收入
产品
最新动态

Ulrich GmbH & Co. KG

公司概况
公司收入
产品
最新动态

Guerbet Group

公司概况
公司收入
产品
最新动态

Vivid Imaging

公司概况
公司收入
产品
最新动态

Sino Medical Device Technology Co. Ltd.

公司概况
公司收入
产品
最新动态

Apollo RT Co. Ltd.

公司概况
公司收入
产品
最新动态

Nemoto Kyorindo Co. Ltd

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215162

The global demand for Contrast Injector Market is presumed to reach the market size of nearly USD 2158.14 Million by 2032 from USD 1015.26 Million in 2023 with a CAGR of 8.74% under the study period 2024-2032.

Contrast injector is a machine used for injecting contrast agents intravenously during MRI scans as it improves visibility of veins, arteries, and tissues present in the body. The device helps to maintain a smooth and controlled flow of contrast throughout the imaging process. It is used in minimally invasive surgical procedures, as it provides high-quality images of the surgical site, thereby helping surgeons to operate in the appropriate place. The computerized version is identified as auto-injectors. It has the ability to control the amount of contrast media that is injected and also the utilization rate. For auto-injectors, the dose of contrast media can be adjusted depending on how fast the medical imaging scanner is.

MARKET DYNAMICS

The rise in the number of minimally-invasive surgeries, increasing incidence of chronic, cardiac, orthopedic and neurological diseases and an increase in the number of diagnostic centers are some key driving factors for contrast media injector market growth. Other factors contributing to the market growth are approvals by government bodies, grants from government organizations, and growing investment related to contrast media. Furthermore, technological advancements in the contrast media injector field will make medical imaging even better and fuel market growth. However, the high cost associated with contrast media injectors and accessories and the risk of putting contrast media inside the injector is expected to hamper the market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Contrast Injector. The growth and trends of Contrast Injector industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Contrast Injector market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Injector Systems
Consumables
Accessories

By Application

Radiology
Interventional Cardiology
Interventional Radiology

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Contrast Injector market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Contrast Injector market include Bayer HealthCare, GE Healthcare, Bracco Imaging S.P.A., AngioDynamics, Medtron AG, Ulrich GmbH & Co. KG, Guerbet Group, Vivid Imaging, Sino Medical Device Technology Co. Ltd., Apollo RT Co. Ltd., Nemoto Kyorindo Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CONTRAST INJECTOR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Injector Systems Historic and Forecast Sales By Regions
5.4. Consumables Historic and Forecast Sales By Regions
5.5. Accessories Historic and Forecast Sales By Regions

6. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Radiology Historic and Forecast Sales By Regions
6.4. Interventional Cardiology Historic and Forecast Sales By Regions
6.5. Interventional Radiology Historic and Forecast Sales By Regions

7. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONTRAST INJECTOR COMPANIES

8.1. Contrast Injector Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF CONTRAST INJECTOR INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Bayer HealthCare
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. GE Healthcare
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Bracco Imaging S.P.A.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. AngioDynamics
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Medtron AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Ulrich GmbH & Co. KG
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Guerbet Group
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Vivid Imaging
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sino Medical Device Technology Co. Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Apollo RT Co. Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Nemoto Kyorindo Co. Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments